About AbbVie
AbbVie is a company based in Chicago (United States) founded in 2012.. The company has 55,000 employees as of December 31, 2024. AbbVie has completed 17 acquisitions, including AMAL Therapeutics, Aliada Therapeutics and Allergan. AbbVie operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Chicago, United States
- Employees 55000 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Abbvie Inc.
-
Annual Revenue
$56.33 B3.71as on Dec 31, 2024
-
Net Profit
$4.24 B-12.07as on Dec 31, 2024
-
EBITDA
$25.01 B-6.61as on Dec 31, 2024
-
Latest Funding Round
$5.9 B (USD), Debt – Conventional
Oct 03, 2018
-
Investors
-
Employee Count
55000
as on Dec 31, 2024
-
Investments & Acquisitions
AMAL Therapeutics
& 16 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of AbbVie
AbbVie is a publicly listed company on the NYSE with ticker symbol ABBV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Leadership Team
326 people
Software Development Team
295 people
Sales and Marketing
173 people
Senior Team
76 people
Product Management Team
75 people
Human Resources and Administration
63 people
Operations Team
56 people
Data Analysis and Operations Team
47 people
Unlock access to complete
Funding Insights of AbbVie
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Conventional — $5.9B
-
First Round
First Round
(05 Nov 2012)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2018 | Amount | Debt – Conventional - AbbVie | Valuation |
investors |
|
| Jun, 2018 | Amount | Debt – Conventional - AbbVie | Valuation |
investors |
|
| Nov, 2012 | Amount | Post-IPO - AbbVie | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by AbbVie
AbbVie has strategically engaged in corporate development activities, having acquired 17 companies. Notable acquisitions include AMAL Therapeutics, Aliada Therapeutics and Allergan. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of drug research & development services for multiple therapeutic areas
|
2021 | ||||
|
Cell therapies are developed for oncology and other diseases.
|
2021 | ||||
|
Combinatorial chemistry services for peptide-based drug discovery are provided.
|
2019 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - AbbVie
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Abbvie Comparisons
Competitors of AbbVie
AbbVie operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Abbvie
Frequently Asked Questions about AbbVie
When was AbbVie founded?
AbbVie was founded in 2012.
Where is AbbVie located?
AbbVie is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
How many employees does AbbVie have?
As of Dec 31, 2024, the latest employee count at AbbVie is 55,000.
What is the annual revenue of AbbVie?
Annual revenue of AbbVie is $56.33B as on Dec 31, 2024.
What does AbbVie do?
AbbVie was established in 2012 and is based in Chicago, United States, within the biopharmaceutical sector. Global operations involve the creation of treatments for autoimmune diseases and other conditions, including adalimumab marketed as Humira, alongside AndroGel, Kaletra, and Norvir. Medicines are distributed worldwide through research-driven processes. In 2022, revenues totaling 56.74 billion were reported, with net profits reaching 7.54 billion.
Who are the top competitors of AbbVie?
AbbVie's top competitors include Merck, Roivant Sciences and Lilly.
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded on NYSE under the ticker symbol ABBV.
How many acquisitions has AbbVie made?
AbbVie has made 17 acquisitions, including AMAL Therapeutics, Aliada Therapeutics, and Allergan.
What is AbbVie's ticker symbol?
The ticker symbol of AbbVie is ABBV on NYSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.